Clinical criteria for the diagnosis of bullous pemphigoid: A reevaluation according to immunoblot analysis of patient sera

Dermatology

Volumn 208, Issue 1, 2004, Pages 16-20

  Joly, P ^a   Courville, Ph ^a   Lok, C ^b   Bernard, Ph ^c   Saiag, Ph ^d   Dreno, B ^e   Delaporte, E ^f   Bedane, C ^g   Picard, C ^h   Sassolas, B ⁱ   Plantin, P ^j   D'Incan, M ^k   Chosidow, O ^l   Pauwels, C ^m   Lambert, D ⁿ   Loche, F ^o   Prost, C ^p   Tancrede Bohin, E ^q   Guillaume, J C ^r   Roujeau, J C ^s   Gilbert, D ^a   Tron, F ^a   Vaillant, L ^a   more..

^a HÔPITAL CHARLES NICOLLE   (France)

^b AMIENS UNIVERSITY HOSPITAL   (France)

^c REIMS UNIVERSITY HOSPITAL   (France)

^d HÔPITAL AMBROISE PARÉ   (France)

^e NANTES UNIVERSITY HOSPITAL   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g LIMOGES UNIVERSITY HOSPITAL   (France)

^h BICHAT HOSPITAL   (France)

ⁱ BREST UNIVERSITY HOSPITAL   (France)

^j Service de Dermatologie   (France)

^k Service de Dermatologie   (France)

^l PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^m Service de Dermatologie   (France)

ⁿ DIJON UNIVERSITY HOSPITAL   (France)

^o TOULOUSE UNIVERSITY HOSPITAL   (France)

^p SAINT LOUIS HOSPITAL   (France)

^q Service de Dermatologie   (France)

^r HENRI MONDOR HOSPITAL   (France)

^s UNIVERSITY HOSPITAL OF TOURS   (France)

more..

Author keywords

Autoimmune blistering diseases; Bullous pemphigoid

Indexed keywords

ANTIGEN; BULLOUS PEMPHIGOID ANTIGEN 1; BULLOUS PEMPHIGOID ANTIGEN 2; UNCLASSIFIED DRUG;

AGED; ANTIGEN RECOGNITION; ARTICLE; BLISTER; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIAGNOSTIC PROCEDURE; HUMAN; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; PEMPHIGOID; PRIORITY JOURNAL; PROGNOSIS; SERODIAGNOSIS; VALIDATION PROCESS;

AGED; AUTOANTIBODIES; AUTOANTIGENS; CARRIER PROTEINS; COLLAGEN; CYTOSKELETAL PROTEINS; DIAGNOSIS, DIFFERENTIAL; HUMANS; IMMUNOBLOTTING; NERVE TISSUE PROTEINS; NON-FIBRILLAR COLLAGENS; PEMPHIGOID, BULLOUS; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 9144252519     PISSN: 10188665     EISSN: None     Source Type: Journal    
DOI: 10.1159/000075040     Document Type: Article

References (35)

1. Bernard P, Vaillant L, Labeille B, et al, and the Bullous Diseases French Study Group: Incidence and distribution of subepidermal autoimmune bullous skin diseases in three French regions. Arch Dermatol 1995;131:48-52.
2. Zillikens D, Wever S, Roth A, Hashimoto T, Brocker EB: Incidence of autoimmune subepidermal blistering dermatoses in a region of central Germany. Arch Dermatol 1995;131:957-958.
3. Mueller S, Klaus-Kovtun V, Stanley JR: A 230-kD basic protein is the major bullous pemphigoid antigen. J Invest Dermatol 1989;92:33-38.
4. Stanley JR, Tanaka T, Mueller S, Klaus-Kovtun V, Roop D: Isolation of complementary DNA for bullous pemphigoid antigen by use of patients' autoantibodies. J Clin Invest 1988;82: 1864-1870.
5. Gammon WR, Murrell DF, Jenison MW, et al: Autoantibodies to type VII collagen recognize epitopes in a fibronectin-like region of the non-collagenous (NC1) domain. J Invest Dermatol 1993;100:618-622.
6. Gammon WR, Briggaman RA: Bullous SLE: A phenotypically distinctive but immunologically heterogeneous bullous disorder. J Invest Dermatol 1993;100:285-345.
7. Bernard P, Prost C, Durepaire N, Basset-Seguin N, Didierjean L, Saurat JH: The major cicatricial pemphigoid antigen is a 180 kD protein which shows immunologic cross-reactivities with the bullous pemphigoid antigen. J Invest Dermatol 1992;99:174-179.
8. Tani M, Murata Y, Masaki H: Pemphigoid nodularis. J Am Acad Dermatol 1989;21: 1099-1104.
9. Levine N, Freilich A, Barland P: Localized pempigoid simulating dyshidrosiform dermatitis. Arch Dermatol 1979;115:320-321.
10. Kuokkanen K, Helin H: Pemphigoid vegetans. Arch Dermatol 1981;117:56-57.
11. Korman NJ, Woods S: Erythrodermic bullous pemphigoid is a clinical variant of bullous pemphigoid. Br J Dermatol 1995;133:967-971.
12. Roenigk HH, Ryan JG, Bergfeld WF: Epidermolysis bullosa acquisita: Report of 3 cases and review of all published cases. Arch Dermatol 1977;113:1-10.
13. Tanaka T, Hashimoto T, Dykes PJ, Nishikawa T: Clinical manifestation in 100 Japanese bullous pemphigoid cases in relation to autoantigen profiles. Clin Exp Dermatol 1996;21:23-27.
14. Prost C, Labeille B, Chaussade V, Guillaume JC, Martin N, Dubertret L: Immunoelectron microscopy in subepidermal autoimmune bullous disease: A prospective study of IgG and C3 bound in vivo in 32 patients. J Invest Dermatol 1987;89:567-573.
15. Crow LL, Finkle JP, Gammon WR, Woodley DT: Clearing of epidermolysis bullosa acquisita with cyclosporine. J Am Acad Dermatol 1988;19:937-942.
16. Guillaume JC, Vaillant L, Bernard P, et al: Controlled trial of azathioprine and plasma exchange in addition to prednisolone in the treatment of bullous pemphigoid. Arch Dermatol 1993;129:49-53.
17. Westerhof W: Treatment of bullous pemphigoid with topical clobetasol propionate. J Am Acad Dermatol 1989;20:458-461.
18. Joly P, Roujeau JC, Benichou J, et al: Comparison of oral and topical corticosteroids in patients with bullous pemphigoid. N Engl J Med 2002;346:321-327.
19. Gammon WR, Briggaman RA, Inman AO, et al: Differentiating anti-lamina-lucida and anti-sublamina densa anti-BMZ antibodies by indirect immunofluorescence on 1.0 M sodium chloride-separated skin. J Invest Dermatol 1984;82:139-144.
20. Gohestani R, Kanitakis J, Nicolas JF, et al: A comparative sensitivity indirect immunofluorescence to immunoblot assay for the detection of circulating antibodies to bullous pemphigoid antigens 1 and 2. Br J Dermatol 1996;135:74-79.
21. Machado P, Michalaki H, Roche P, et al: Serological diagnosis of bullous pemphigoid: Comparison of the sensibility of indirect immunofluorescence on salt-split skin to immunoblotting. Br J Dermatol 1992;126:236-241.
22. Bernard P, Didierjean L, Denis F, et al: Heterogenous bullous pemphigoid antibodies: Detection and characterization by immunoblotting when absent by indirect immunofluorescence. J Invest Dermatol 1989;92:171-174.
23. Ghohestani R, Nicolas JF, Rousselle P, Claudy A: Diagnostic value of indirect immunofluorescence on sodium chloride-split skin in differential diagnosis of subepidermal autoimmune bullous dermatoses. Arch Dermatol 1997;133: 1102-1107.
24. Domloge-Hutsch N, Anhalt GJ, Gammon WR, et al: Anti-epiligrin cicatricial pemphigoid: A subepithelial bullous disorder. Arch Dermatol 1994;130:1521-1529.
25. Gammon WR, Kowalewski C, Chorzelski TP, et al: Direct immunofluorescence studies of sodium chloride-separated skin in the differential diagnosis of bullous pemphigoid and epidermolysis bullosa acquisita. J Am Acad Dermatol 1990;22:664-670.
26. Joly P, Gilbert D, Thomine E, et al: Relationship between the in vivo localization and the immunoblotting pattern of anti-basement membrane zone antibodies in patients with bullous pemphigoid. Arch Dermatol 1997;133: 719-724.
27. Vaillant L, Bernard P, Joly P, et al, for the French Bullous Study Group: Evaluation of clinical criteria for diagnosis of bullous pemphigoid. Arch Dermatol 1998;134:1075-1080.
28. Prost C, Dubertret L, Fosse M, et al: A routine immunoelectron microscopic technique for localizing an autoantibody on epidermal basement membrane. Br J Dermatol 1984;110:1-7.
29. Bedane C, Prost C, Bernard P, et al: Cicatricial pemphigoid antigen differs from bullous pemphigoid antigen by its exclusive extracellular localization: A study by indirect immunoelectron miscroscopy. J Invest Dermatol 1991;97: 3-9.
30. Bernard P, Prost C, Lecerf V, et al: Studies of cicatricial pemphigoid autoantibodies using direct immunoelectron microscopy and immunoblot analysis. J Invest Dermatol 1990;94: 630-635.
31. Korman NJ: The latest in diagnosis, prognosis and therapy. Arch Dermatol 1998;134:1137-1141.
32. Bernard P: Recent advances on the 180-kD epidermal antigen in autoimmune subepidermal skin diseases. Springer Semin Immunopathol 1992;13:401-412.
33. Liu Z, Diaz LA, Troy JL, et al: A passive transfer model of the organ-specific autoimmune disease, bullous pemphigoid using antibodies generated against the hemidesmosomal antigen BP 180. J Clin Invest 1993;92:2480-2488.
34. Woodley DT, Briggaman RA, O'Keefe EJ, et al: Identification of the skin basement membrane autoantigen in epidermolysis bullosa acquisita. N Engl J Med 1984;310:1007-1013.
35. Zillikens D, Mascaro JM, Rose PR, et al: A highly sensitive enzyme-linked immunosorbent assay for the detection of circulating anti-BP180 autoantibodies in patients with bullous pemphigoid. J Invest Dermatol 1997;109:679-683.